Fig. 4From: Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancerForest plots of the pooled RR for overall survival (OS) of concurrent regimens and sequential regimens. The results indicated that there was no significant difference in OS between concurrent and sequential groups (RR, 1.03; 95% CI, 0.94 to 1.13, P = 0.51)Back to article page